age_at_diagnosis,chemotherapy,cohort,neoplasm_histologic_grade,hormone_therapy,lymph_nodes_examined_positive,mutation_count,nottingham_prognostic_index,overall_survival_months,overall_survival,radio_therapy,tumor_size,tumor_stage,death_from_cancer,brca1,brca2,palb2,pten,tp53,egfr,atm,cdh1,chek2,stk11,bard1,casp8,cyp19a1,map3k1,nbn,rad51c,tert,nf1,pik3ca,mlh1,msh2,type_of_breast_surgery_BREAST CONSERVING,type_of_breast_surgery_MASTECTOMY,type_of_breast_surgery_nan,cancer_type_Breast Cancer,cancer_type_Breast Sarcoma,cancer_type_nan,cancer_type_detailed_Breast,cancer_type_detailed_Breast Invasive Ductal Carcinoma,cancer_type_detailed_Breast Invasive Lobular Carcinoma,cancer_type_detailed_Breast Invasive Mixed Mucinous Carcinoma,cancer_type_detailed_Breast Mixed Ductal and Lobular Carcinoma,cancer_type_detailed_Metaplastic Breast Cancer,cancer_type_detailed_nan,cellularity_High,cellularity_Low,cellularity_Moderate,cellularity_nan,pam50_+_claudin-low_subtype_Basal,pam50_+_claudin-low_subtype_Her2,pam50_+_claudin-low_subtype_LumA,pam50_+_claudin-low_subtype_LumB,pam50_+_claudin-low_subtype_NC,pam50_+_claudin-low_subtype_Normal,pam50_+_claudin-low_subtype_claudin-low,pam50_+_claudin-low_subtype_nan,er_status_measured_by_ihc_Negative,er_status_measured_by_ihc_Positve,er_status_measured_by_ihc_nan,er_status_Negative,er_status_Positive,er_status_nan,her2_status_measured_by_snp6_GAIN,her2_status_measured_by_snp6_LOSS,her2_status_measured_by_snp6_NEUTRAL,her2_status_measured_by_snp6_UNDEF,her2_status_measured_by_snp6_nan,her2_status_Negative,her2_status_Positive,her2_status_nan,tumor_other_histologic_subtype_Ductal NST,tumor_other_histologic_subtype_Lobular,tumor_other_histologic_subtype_Medullary,tumor_other_histologic_subtype_Metaplastic,tumor_other_histologic_subtype_Mixed,tumor_other_histologic_subtype_Mucinous,tumor_other_histologic_subtype_Other,tumor_other_histologic_subtype_Tubular  cribriform,tumor_other_histologic_subtype_nan,inferred_menopausal_state_Post,inferred_menopausal_state_Pre,inferred_menopausal_state_nan,integrative_cluster_1,integrative_cluster_10,integrative_cluster_2,integrative_cluster_3,integrative_cluster_4ER+,integrative_cluster_4ER-,integrative_cluster_5,integrative_cluster_6,integrative_cluster_7,integrative_cluster_8,integrative_cluster_9,integrative_cluster_nan,primary_tumor_laterality_Left,primary_tumor_laterality_Right,primary_tumor_laterality_nan,oncotree_code_BREAST,oncotree_code_IDC,oncotree_code_ILC,oncotree_code_IMMC,oncotree_code_MBC,oncotree_code_MDLC,oncotree_code_nan,pr_status_Negative,pr_status_Positive,pr_status_nan,3-gene_classifier_subtype_ER+ HER2- High Prolif,3-gene_classifier_subtype_ER+ HER2- Low Prolif,3-gene_classifier_subtype_ER- HER2-,3-gene_classifier_subtype_HER2+,3-gene_classifier_subtype_nan
85.49,0,1,2,1,0,1,3.044,132.0333333,0,1,22,4,Died of Disease,-0.4601,-0.2692,-0.7247,-0.6742,-0.6333,-0.5534,-0.6192,0.2709,-0.498,0.6121,-0.7947,0.262,-0.833,-1.6,1.2944,1.4494,-1.3581,0.1006,-0.9071,1.7251,-1.096,0,1,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0
